Page 5,417«..1020..5,4165,4175,4185,419..5,4305,440..»

Pharmacy program loses accreditation points

Posted: Published on April 21st, 2013

HILO The University of Hawaiis Daniel K. Inouye College of Pharmacy came up short this week when the schools lack of permanent facilities cost it points in an accreditation evaluation. Visiting the Hilo campus on Monday and Tuesday, the evaluation team sent by the Accreditation Council for Pharmacy Education found the college to be lacking when it came to providing physical facilities. Currently, pharmacy students are spread out at various locations around Hilo, including in temporary trailer classrooms off Komohana Street. Of the 30 standards that comprise ACPE Standards 2007, the evaluation team found that the College was in compliance with all but one, wrote evaluation consultant Max D. Ray in a preliminary summary of findings following the visit. With respect to Standard 27 (physical facilities), the team found the college to be noncompliant. The University is currently working with the Legislature to procure the $38 million in funding it needs for a permanent building. The state Senate has funded the project in its version of the state budget, but the state House of Representatives dropped a line item for the college from its version about halfway through the current session. The currently Legislative session will come to a close … Continue reading →

Posted in Pharmacy | Comments Off on Pharmacy program loses accreditation points

Fla-based compounding pharmacy recalls dozens of sterile drug products, including injectables

Posted: Published on April 21st, 2013

By The Associated Press LAKE MARY, Fla. - A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria, Food and Drug Administration officials said Sunday. The FDA encouraged health care facilities and providers who have received sterile products, including all injectables, from Balanced Solutions Compounding Pharmacy to immediately check their medical supplies, quarantine the products, and follow the company's recall instructions. Patients who were administered any sterile drug products produced and distributed by Balanced Solutions should contact their health care providers. The recall includes a few dozen sterile products furnished nationwide, according to a statement from the company. The majority of the products were injectable drugs. An FDA inspection of the company revealed "poor practices and conditions which may have exposed the company's sterile products to microbial contamination," officials said in a statement. The FDA sampled chromium chloride injections from Balanced Solutions and identified gram-negative bacteria in the product, which can cause disease and many types of infection. But officials said the bacteria do not usually cause infection in humans. Balanced Solutions is a division of Axium Healthcare Pharmacy Inc., which is … Continue reading →

Posted in Pharmacy | Comments Off on Fla-based compounding pharmacy recalls dozens of sterile drug products, including injectables

Pharmacy safety bill goes to public hearing Monday

Posted: Published on April 21st, 2013

6:37 PM Rep. Sharon Treat's bill seeks to avoid repeat of problems that plagued Mass. compounding pharmacy recently By Susan M. Cover scover@mainetoday.com State House Bureau AUGUSTA The deaths of 53 people after a nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts has prompted a local lawmaker to put in a bill to strengthen regulations in Maine. click image to enlarge Pharmacy technician Suzanne Goddard works under a hood, preparing bags of intravenous medicines, in the sterile room on April 12 at Kennebec Pharmacy & Home Care in Augusta. Staff photo by Joe Phelan click image to enlarge Pharmacy technician Suzanne Goddard works under a hood, preparing intravenous bags of medicines, in the sterile room on April 12, at Kennebec Pharmacy & Home Care in Augusta. Staff photo by Joe Phelan "We need to make sure what happened at that Massachusetts pharmacy could never happen in Maine," said Rep. Sharon Anglin Treat, D-Hallowell. "One of the reasons we have these issues is we have no unified federal law to deal with compounding pharmacies." See the article here: Pharmacy safety bill goes to public hearing Monday … Continue reading →

Posted in Pharmacy | Comments Off on Pharmacy safety bill goes to public hearing Monday

Fla. compounding pharmacy recalls sterile drugs

Posted: Published on April 21st, 2013

LAKE MARY, Fla. (AP) -- A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria, Food and Drug Administration officials said Sunday. The FDA encouraged health care facilities and providers who have received sterile products, including all injectables, from Balanced Solutions Compounding Pharmacy to immediately check their medical supplies, quarantine the products, and follow the company's recall instructions. Patients who were administered any sterile drug products produced and distributed by Balanced Solutions should contact their health care providers. The recall includes a few dozen sterile products furnished nationwide, according to a statement from the company. The majority of the products were injectable drugs. An FDA inspection of the company revealed "poor practices and conditions which may have exposed the company's sterile products to microbial contamination," officials said in a statement. The FDA sampled chromium chloride injections from Balanced Solutions and identified gram-negative bacteria in the product, which can cause disease and many types of infection. But officials said the bacteria do not usually cause infection in humans. Balanced Solutions is a division of Axium Healthcare Pharmacy Inc., which is based in Lake … Continue reading →

Posted in Pharmacy | Comments Off on Fla. compounding pharmacy recalls sterile drugs

Stem cell donor ditches Stanford University professor

Posted: Published on April 21st, 2013

MUMBAI: Healthy stem cells from a person of the same genetic make can mean life for Stanford University professor Nalini Ambady, or death if she doesn't find a donor in a month's time. A matching donor, recently found in Mumbai after an almost six-month-long search across India, backed out after initially consenting to stem-cell donation. When her eight-year-old leukemia made a comeback last year, doctors in the US suggested she look for an Indian donor for a greater match probability, given ethnic similarities. After failing to find a match in the US' National Marrow Donor Program (NMDP) that boasts of a database of 10 million registered donors, Ambady's family finally directed their search towards India last November. Yet, two prominent stem cell donor registries in India with a combined pool of 50,000 donors could not find a match until recently. Beating the odds of one in over 20,000, the unexpected happened last week when city-based Marrow Donor Registry of India (MDRI) found the Human Leukocyte Antigens (HLAs) match in a software engineer. HLA match refers to immunological compatibility, and doctors look for a match in at least 10 counts of crucial antigens to go ahead with a transplant. Coincidentally, not … Continue reading →

Comments Off on Stem cell donor ditches Stanford University professor

Drake Institute Scam debunked Call (949) 653-2020 Drake Institute Reviews – Video

Posted: Published on April 20th, 2013

Drake Institute Scam debunked Call (949) 653-2020 Drake Institute Reviews Click here http://www.drakeinstitute.com for more information. Drake Institute Scam is a hoax. The Drake Institute is a well known behavioral medicine clinic... By: adhdtreatmentadult … Continue reading →

Comments Off on Drake Institute Scam debunked Call (949) 653-2020 Drake Institute Reviews – Video

ACT Today! Reaches $1 Million Milestone in Helping Families Impacted with Autism

Posted: Published on April 20th, 2013

ACT Today! (Autism Care and Treatment Today!) announces the non-profit organization has awarded one million dollars in care and treatment to families in need, as of March 2013. Nationwide (PRWEB) April 19, 2013 Our goal is to introduce and help facilitate early and on-going treatment by providing the necessary resources (including referrals, funding and guidance) to individuals with autism and their families, says ACT Today!s executive director Nancy Alspaugh-Jackson. ACT Today! is proud to offer an assistance program for assessments, treatments, and life supports that may not otherwise be covered privately or by other third-party funding sources such as school districts, county programs, insurance, and/or other grant making entities. The ACT Today! Assistance Program funds are allocated based on annual fundraising activities. The Board of Directors determines the number and amounts of each grant at the beginning of each term. Requests for endowments or multi-year grants are not accepted. Applicants must demonstrate financial need by providing the following: For more information about the ACT Today! Assistance Program, visit http://www.act-today.org/act-today-grant-program.php. About ACT Today!: ACT Today! (Autism Care and Treatment Today!) is a 501(c)(3) non-profit organization dedicated to providing resources and funding to families of children with autism who cannot afford or … Continue reading →

Comments Off on ACT Today! Reaches $1 Million Milestone in Helping Families Impacted with Autism

BioTime Enters Into License Agreement With UCLA To Develop Therapy For Stroke

Posted: Published on April 20th, 2013

By RTT News, April 19, 2013, 09:27:00 AM EDT (RTTNews.com) - Healthcare company BioTime, Inc. ( BTX ) Friday said it has entered into an exclusive license agreement with the University of California, Los Angeles, or UCLA, for the development of technology related to the treatment of stroke. The company said the licensed technology, developed in the labs of Tom Carmichael, MD, PhD of UCLA'sDepartment of Neurology, at the David Geffen School of Medicine, uses one of BioTime's HyStem hydrogels to deliver locally released growth factors to improve recovery from stroke. It further added that pre-clinical studies have demonstrated that the localized delivery of growth factors such as brain-derived neurotrophic factor results in a statistically significant improvement in post-stroke motor function in a murine model of ischemic stroke. The firm has, at the same time, entered into a Sponsored Research Agreement with UCLA to support the on-going pre-clinical work in Dr. Carmichael's laboratory to advance the understanding of this technology and develop data in support for the potential filing of an Investigational New Drug Application for human clinical trails. For comments and feedback: contact editorial@rttnews.com http://www.rttnews.com Read the original post: BioTime Enters Into License Agreement With UCLA To Develop Therapy … Continue reading →

Comments Off on BioTime Enters Into License Agreement With UCLA To Develop Therapy For Stroke

BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke

Posted: Published on April 20th, 2013

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of stroke. The licensed technology, developed in the laboratories of Tom Carmichael, MD, PhD of UCLAs Department of Neurology, at the David Geffen School of Medicine, uses one of BioTimes HyStem hydrogels to deliver locally released growth factors to improve recovery from stroke. Pre-clinical studies have demonstrated that the localized delivery of growth factors such as brain-derived neurotrophic factor (BDNF) results in a statistically significant improvement in post-stroke motor function in a murine model of ischemic stroke. Concurrent with the execution of this exclusive license agreement, BioTime has entered into a Sponsored Research Agreement with UCLA to support on-going pre-clinical work in Dr. Carmichaels laboratory to advance the understanding of this technology and develop data in support for the potential filing of an Investigational New Drug Application (IND) for human clinical trails. About BioTime, Inc. BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell technologies is enhanced through subsidiaries focused on … Continue reading →

Comments Off on BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke

Local family shows bravery in the face of Parkinson disease

Posted: Published on April 20th, 2013

By Kay Quinn Healthbeat Reporter ST. LOUIS (KSDK) - Parkinson disease affects a million Americans. Actor Michael J. Fox has it, and St. Louis broadcaster Jack Buck was diagnosed before his death in 2002. Now, you can help support those with Parkinson by playing in a golf tournament to raise money for research and support for those with the disease. Here's a look what it means to live with this disease and the local effort to combat it. "We have always been an upbeat family," said Lynda Wiens, "you always look for a silver lining, and you always find one." Almost three decades ago, Lynda and Bob Wiens moved to St. Louis from Canada and raised two sons. She was a nurse, he was a cardiologist. Bob was the physician on call for visiting presidents, the pope, and the Dean of St. Louis University's Medical School. Then in the late 1980s he diagnosed himself with the symptoms of Parkinson disease. "My son was about nine years, 10-years-old probably, and he wanted to know why dad could play ball with him one day and not the other," recalled Lynda. Parkinson is a neurological disease that causes tremors, slow movements and problems … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Local family shows bravery in the face of Parkinson disease

Page 5,417«..1020..5,4165,4175,4185,419..5,4305,440..»